Association of chronic hepatitis B infection with hepatic steatosis and injury in nonalcoholic fatty liver disease children
- PMID: 38166674
- PMCID: PMC10759402
- DOI: 10.1186/s12876-023-03103-9
Association of chronic hepatitis B infection with hepatic steatosis and injury in nonalcoholic fatty liver disease children
Abstract
Background: The influence of chronic hepatitis B infection (CBI) on hepatic steatosis, necroinflammation, and fibrosis in nonalcoholic fatty liver disease (NAFLD) population was unclear. We aimed to investigate the effect of CBI on hepatic steatosis and assess the association between NAFLD co-existed CBI and hepatic injury in NAFLD pediatric population.
Methods: Consecutive hospitalized children with biopsy-proven NAFLD with or without CBI were included. Hepatic steatosis, necroinflammation and fibrosis were evaluated by NASH CRN system and/or METAVIR scoring system, appropriately. Using multivariate logistic analysis, we identified variables associated with hepatic steatosis and liver injury.
Results: Of 223 biopsy-proven NAFLD children, 161 were NAFLD without CBI, and 62 were NAFLD co-existed CBI. Grouped by mild, moderate and severe hepatic steatosis, there was an inverse association between CBI and the severity of hepatic steatosis [odd ratio (OR) 0.037, 95% confidence interval (CI) 0.014-0.098]. In addition, we explored the relationship between CBI and hepatic necroinflammation and fibrosis in NAFLD children. Hepatic necroinflammation and fibrosis, respectively, were divided into two groups according to severity. And CBI was positively associated with hepatic necroinflammation (OR 6.125, 95%CI 1.958-19.158). However, there was no statistically independent association between CBI and significant hepatic fibrosis.
Conclusions: CBI was inverse associated with the grade of steatosis and positively associated with severe hepatic necroinflammation, and does not appear to affect significant hepatic fibrosis in pediatric NAFLD children.
Keywords: Chronic hepatitis B infection (CBI); Nonalcoholic fatty liver disease (NAFLD); Pediatric population.
© 2023. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Similar articles
-
Nonalcoholic fatty liver disease is associated with lower hepatitis B viral load and antiviral response in pediatric population.J Gastroenterol. 2019 Dec;54(12):1096-1105. doi: 10.1007/s00535-019-01594-6. Epub 2019 May 27. J Gastroenterol. 2019. PMID: 31134334
-
Application of Fatty Liver Inhibition of Progression Algorithm and Steatosis, Activity, and Fibrosis Score to Assess the Impact of Non-Alcoholic Fatty Liver on Untreated Chronic Hepatitis B Patients.Front Cell Infect Microbiol. 2022 Jan 17;11:733348. doi: 10.3389/fcimb.2021.733348. eCollection 2021. Front Cell Infect Microbiol. 2022. PMID: 35111690 Free PMC article.
-
[Clinical study of non-alcoholic fatty liver disease and its combined the chronic HBV infection].Zhonghua Gan Zang Bing Za Zhi. 2017 Aug 20;25(8):618-622. doi: 10.3760/cma.j.issn.1007-3418.2017.08.012. Zhonghua Gan Zang Bing Za Zhi. 2017. PMID: 29056013 Chinese.
-
Radiologic evaluation of nonalcoholic fatty liver disease.World J Gastroenterol. 2014 Jun 21;20(23):7392-402. doi: 10.3748/wjg.v20.i23.7392. World J Gastroenterol. 2014. PMID: 24966609 Free PMC article. Review.
-
Risk for hepatic and extra-hepatic outcomes in nonalcoholic fatty liver disease.J Intern Med. 2022 Aug;292(2):177-189. doi: 10.1111/joim.13343. Epub 2021 Jul 6. J Intern Med. 2022. PMID: 34118091 Review.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous